Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVACINCAPTAD PEGOL vs RAVULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVACINCAPTAD PEGOL vs RAVULIZUMAB: Safety Overview

Metric AVACINCAPTAD PEGOL RAVULIZUMAB
Total FAERS Reports 202 118
Deaths Reported 3 11
Death Rate 1.5% 9.3%
Hospitalizations 2 89
Average Patient Age 82.3 yrs 48.4 yrs
% Female Patients 61.9% 56.3%
FDA Approval Date Aug 4, 2023 N/A
Manufacturer Astellas Pharma US, Inc. Alexion Pharmaceuticals Inc.
Route INTRAVITREAL INTRAVENOUS
Marketing Status Prescription N/A